Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 243.00
Bid: 244.00
Ask: 247.00
Change: 3.00 (1.25%)
Spread: 3.00 (1.23%)
Open: 244.00
High: 248.00
Low: 237.00
Prev. Close: 240.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Prospectus

25 Nov 2019 12:55

RNS Number : 5650U
Galliford Try PLC
25 November 2019
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

25 November 2019

 

For immediate release

 

Galliford Try plc

Publication of Prospectus

Further to its announcement made on 7 November 2019 regarding the proposed disposal of the Linden Homes and Partnerships & Regeneration divisions of Galliford Try plc ("Galliford Try") (the "Transaction"), Galliford Try announces that the Financial Conduct Authority has today approved a prospectus (the "Prospectus") in relation to the proposed admission of the ordinary shares of Galliford Try Holdings plc ("New Galliford Try") to listing on the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities.

The Prospectus will shortly be submitted to the National Storage Mechanism and be available for inspection at www.morningstar.co.uk/uk/nsm. The Prospectus will also shortly be available for viewing on Galliford Try's website at www.gallifordtry.co.uk.

Unless otherwise defined, terms used in this announcement (including in the Important Notice below) shall have the same meaning as those used in the Prospectus.

Enquiries:

Galliford Try plc

Graham Prothero, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel and Company Secretary

 

01895 855 001

 

Rothschild & Co (Lead Financial Adviser to Galliford Try and New Galliford Try)

John Deans

Neil Thwaites

Peter Everest

 

020 7280 5000

HSBC Bank plc (Joint Financial Adviser, Joint Sponsor and Joint Corporate Broker to Galliford Try and New Galliford Try)

Mark Dickenson

Adam Miller

Keith Welch

Diraj Ramchandani

 

020 7991 8888

Peel Hunt LLP (Joint Financial Adviser, Joint Sponsor and Joint Corporate Broker to Galliford Try and New Galliford Try)

Charles Batten

Edward Knight

Harry Nicholas

 

020 7418 8900

Tulchan Communications (PR Adviser to Galliford Try)

James Macey White

Martin Pengelley

Elizabeth Snow

 

020 7353 4200

 

Important Notice

This announcement is for information purposes only and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement shall constitute an offer or invitation to underwrite, buy, subscribe, sell or issue of the solicitation of an offer to buy, sell, acquire, dispose or subscribe for shares of any other securities. Nothing in this announcement should be interpreted as a term or condition of the Transaction.

Copies of the Prospectus will shortly be available for viewing on Galliford Try's website at www.gallifordtry.co.uk. Neither the content of Galliford Try's website nor any website accessible by hyperlinks on Galliford Try's website is incorporated in, or forms part of, this announcement.

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. The information in this announcement is subject to change.

The availability of this announcement and/or the Prospectus to persons who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom or who are subject to the laws and/or regulations of another jurisdiction should inform themselves of, and should observe, any applicable requirements. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction.

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting as lead financial adviser to Galliford Try and New Galliford Try in connection with the proposed sale of the Disposal Group (excluding for the avoidance of doubt the associated restructuring) and admission of the ordinary shares in New Galliford Try to trading on the London Stock Exchange's main market for listed securities and for no one else in connection with the Transaction and will not be responsible to anyone other than Galliford Try or New Galliford Try for providing the protections afforded to clients of Rothschild & Co or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

HSBC Bank plc ("HSBC"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting as joint financial adviser, joint sponsor and joint corporate broker to Galliford Try and New Galliford Try in connection with the proposed sale of the Disposal Group (excluding for the avoidance of doubt the associated restructuring) and admission of the ordinary shares in New Galliford Try to trading on the London Stock Exchange's main market for listed securities and for no one else in connection with the Transaction and will not be responsible to anyone other than Galliford Try or New Galliford Try for providing the protections afforded to clients of HSBC or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Peel Hunt LLP ("Peel Hunt"), which is regulated by the Financial Conduct Authority in the United Kingdom, is acting as joint financial adviser, joint sponsor and joint corporate broker to Galliford Try and New Galliford Try in connection with the proposed sale of the Disposal Group (excluding for the avoidance of doubt the associated restructuring) and admission of the ordinary shares in New Galliford Try to trading on the London Stock Exchange's main market for listed securities and for no one else in connection with the Transaction and will not be responsible to anyone other than Galliford Try or New Galliford Try for providing the protections afforded to clients of Peel Hunt or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

This announcement has been issued by Galliford Try and is the sole responsibility of Galliford Try. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Rothschild & Co, HSBC or Peel Hunt, or by any of their affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to any interested party or its advisers, and any responsibility or liability, whether arising in tort, contract or otherwise in respect of this announcement or any such statement, therefore is expressly disclaimed.

Notice to US Shareholders

The ordinary shares of New Galliford Try have not been and are not required to be registered under the US Securities Act of 1933, as amended. The ordinary shares of New Galliford Try have not been approved or disapproved by the US Securities Exchange Commission, any state securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the issue of the ordinary shares or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PDICKPDPBBDDDDB
Date   Source Headline
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights
17th Nov 20237:00 amRNSCompletion of Share Buyback Programme
16th Nov 20234:30 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20233:00 pmRNSResult of AGM
10th Nov 20237:00 amRNSAGM Statement
9th Nov 20237:00 amRNSAcquisition
8th Nov 20237:00 amRNSDirectorate Change
7th Nov 20237:00 amRNSContract
2nd Nov 20235:51 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20239:14 amRNSTransaction in Own Shares
23rd Oct 202311:05 amRNSDirectorate Change
18th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20233:30 pmRNSAnnual Financial Report
3rd Oct 202310:15 amRNSEmployee Share Trust Trading Plan
2nd Oct 202310:30 amRNSTotal Voting Rights
28th Sep 20233:05 pmRNSDirector/PDMR Shareholding
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20234:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSHolding(s) in Company
21st Sep 20232:30 pmRNSBlock listing Interim Review
20th Sep 20237:00 amRNSFinal Results
12th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.